Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France
Location status: Recruiting
NCT Number: NCT04515459
This Phase II feasibility study, prospective, interventional, monocentric aiming to assess the interest of pre-operative rehabilitation in patients treated for bone or soft-tissue sarcoma of the limbs.
This protocol will be based on the realisation of a surgical prehabilitation program adapted to the patient. This strategy will involve a team of several health professionals: rehabilitation doctor, physiotherapist, occupational therapist, specialised nurse, dietician and adapted physical activity teacher.
The aim of an adapted surgical prehabilitation program is to improve the functional recovery of the treated limb and the patient's autonomy after surgery.
Each patient will be followed until 24 months post surgery.
Interested in participating?
Request Info16 year and older
All sexes
Interventional
Phase 2
Toulouse, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This programme will include the practice of general physical activity and the implementation of nutritional and psychological support.
Each patient will have 8 Oncorehabilitation Transdisciplinary Evaluations (OTE):
During the program (at each OTE), patients will also be asked to complete the QLQ-C30 questionnaire.
Time frame: 26 months for each patient.
Time frame: 26 months for each patient.
Quality of life will be evaluated from OTE1 to OTE8.
Time frame: 26 months for each patient.
Seven item subscale. Each item is scored on a 4-point scale. Anxiety will be evaluated from OTE1 to OTE8.
Time frame: 26 months for each patient.
Seven item subscale. Each item is scored on a 4-point scale. Depression will be evaluated from OTE1 to OTE8.
Time frame: 26 months for each patient.
Time frame: 26 months for each patient.
Time frame: 26 months for each patient.
Time frame: 26 months for each patient.
Time frame: 26 months for each patient.
Time frame: 26 months for each patient.
Time frame: 26 months for each patient.
Contact information is provided by the study sponsor or research team.
Institut Claudius Regaud
Other
Acronym: EPOP-SARCOMA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03356782
Bone Diseases, Bone Neoplasms
Shenzhen, Guangdong, China
View Trial DetailsNCT04433221
Bone Diseases, Bone Neoplasms
Shenzhen, Guangdong, China
View Trial DetailsNCT06129903
Bone Diseases, Bone Neoplasms
Basking Ridge, New Jersey, United States
View Trial DetailsNCT07662239
Bone Diseases, Bone Neoplasms
Boston, Massachusetts, United States
View Trial Details